[1]
Ayten, O. and Şaylan, B. 2020. Comparison of non-severe COVID-19 pneumonia patients treated with lopinavir/ritonavir and favipiravir. Journal of Surgery and Medicine. 4, 11 (Nov. 2020), 970–973. DOI:https://doi.org/10.28982/josam.795283.